Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures
Clinical trial NCT00772603 · COMPLETED
Trial details
- NCT number
- NCT00772603
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-04-01
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.